← Back to Search

Capability-Opportunity-Motivation-Behavior (COM-B) based physical activity behavioral intervention for Multiple Sclerosis

N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing disease-modifying therapy
Diagnosed with multiple sclerosis for 2 or fewer years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial investigates how an online program with newsletters and video conferencing can help people recently diagnosed with MS get more active and reduce fatigue and improve quality of life.

Eligible Conditions
  • Multiple Sclerosis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are currently receiving treatment that alters the course of your disease.
Select...
You have been diagnosed with multiple sclerosis for no more than 2 years.
Select...
You have not experienced a return of your previous medical condition within the past 30 days.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change of Physical Activity levels through Accelerometry from baseline and 12 weeks
Change of Physical Activity levels through the Abbreviated International Physical Activity Questionnaire from baseline and 12 weeks
Change of Physical Activity levels through the Godin Leisure-Time Exercise Questionnaire from baseline and 12 weeks
+4 more
Secondary outcome measures
Change of self-report measures of Fatigue through the Fatigue Severity Scale from baseline and 12 weeks
Changes of self-report measures of quality of life through the Multiple Sclerosis Impact Scale-29 at baseline and 12 weeks
Formative evaluation

Trial Design

1Treatment groups
Experimental Treatment
Group I: Capability-Opportunity-Motivation-Behavior (COM-B) based physical activity behavioral interventionExperimental Treatment1 Intervention
This is a 1-arm study with an intervention condition based on the COM-B model
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical activity behavioral intervention in persons newly diagnosed with MS
2023
N/A
~20

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,565 Previous Clinical Trials
2,268,342 Total Patients Enrolled
37 Trials studying Multiple Sclerosis
45,267 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current opportunities for patients to participate in this research?

"Clinicaltrials.gov has listed this clinical trial as open for recruitment since its initial posting on January 17th, 2023 and the details were most recently revised on January 24th of the same year."

Answered by AI

How many participants are currently undergoing treatment in this clinical trial?

"Absolutely. Per the information displayed on clinicaltrials.gov, this medical trial is actively seeking out participants. It was initiated on 17th January 2023 and its most recent update occurred 24th of that same month. An overall headcount of 20 patients needs to be recruited from a single site for it to commence operations successfully."

Answered by AI
~7 spots leftby Mar 2025